PATENT CLAIM ANALYSIS

Application Number: 15989985
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "015200"]

Abstract:
The invention provides methods and materials for making and using variant serum albumin amino acid sequences which exhibit improved properties compared to wild type serum albumin sequences. The invention further provides methods and materials for making and using fusion proteins in which the variant serum albumin amino acid sequences are fused to a therapeutic or diagnostic agent, such as a therapeutic protein, or a functional fragment or variant thereof that maintains activity, and exhibits improved properties.

Claim (Index 15):
A method of making a variant serum albumin polypeptide (VSA) associated diagnostic agent, the method comprising:\n providing a diagnostic agent; and associating the diagnostic agent with a protein comprising a VSA, which comprises a sequence that is at least 90% identical but less than 100% identical to amino acid residues 380 to 585 of SEQ ID NO: 2 to generate a VSA associated diagnostic agent.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 93.0
- Lexical Diversity: 1.7234
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13985227', '13578688', '14181339', '15915977', '15753947']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7236579312900707
- 35 USC 102 Novelty (BERT): 0.5414496256701244
- Combined Prediction Score: 0.7054371007280761
- Mean Citation Score: 294.638252
- Max Citation Score: 307.64963
- Similarity Product: 234.2528219751656

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test